Turbo-PUVA: Dihydroxyacetone-enhanced photochemotherapy for psoriasis: A pilot study

Archives of Dermatology

Volumn 135, Issue 5, 1999, Pages 540-544

  Taylor, Charles R ^a,c   Kwangsukstith, Chartchai ^b   Wimberly, Joanne ^a   Kollias, N ^a   Anderson, R Rox ^a  

^a HARVARD UNIVERSITY   (United States)

^b CHIANG MAI UNIVERSITY   (Thailand)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROXYACETONE; LACTIC ACID; METHOXSALEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL OBSERVATION; DISEASE SEVERITY; EUROPE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LOTION; MALE; ORAL DRUG ADMINISTRATION; PHOTOCHEMOTHERAPY; PILOT STUDY; PRIORITY JOURNAL; PSORIASIS; PUVA; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; DIHYDROXYACETONE; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PSORIASIS; PUVA THERAPY;

EID: 0032953041     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.135.5.540     Document Type: Article

References (15)

1. Grupper C, Berretti B. Retinoid combinations. In: Roenigk HH, Maibach HI, eds. Psoriasis. New York, NY: Marcel Dekker Inc; 1997:679-703.
2. Tanew A, Guggenbichler A, Hönigsmann H, Geiger JM, Frítsch P. Photochemotherapy for severe psoriasis without or in combination with acitretin: a randomized, double-blind comparison study. J Am Acad Dermatol. 1991;25: 682-684.
3. Morison WL, Momtaz K, Parrish JA, Fitzpatrick TB. Combined methotrexate-PUVA therapy in the treatment of psoriasis. J Am Acad Dermatol. 1982;6:46-51.
4. Levy SB. Dihydroxyacetone-containing sunless or self-tanning lotions. J Am Acad Dermatol. 1992;27:989-993.
5. Lubuza TP, Warren RM, Wirmbier HC. The physical aspects with respect to water and non-enzymatic browning. Adv Exp Med Biol. 1977;86B:379-418.
6. Johnson JA, Fusaro RM. Protection against long ultraviolet radiation: topical browning agents and a new outlook. Dermatologica. 1987;175:53-57.
7. Fusaro RM, Johnson JA. Protection against long ultraviolet and/or visible light with topical dihydroxyacetone. Dermatologica. 1975;150:346-351.
8. Hruza L, Kollias N, Wimberly J, Anderson R. Dihydroxyacetone-enhanced PUVA. Presented at: Annual Meeting of the Photomedicine Society; March 17, 1994; Washington, DC.
9. Ryatt KS, Feather JW, Dawson JB, Cotterill JA. The usefulness of reflectance spectrophotometric measurements during psoralen and ultraviolet A therapy for psoriasis. J Am Acad Dermatol. 1983;9:558-562.
10. Gillies R, Kollias N. Noninvasive in vivo determination of sunscreen ultraviolet A protection factors using diffuse reflectance spectroscopy. In: Lowe NJ, Shaath NA, Pathak MA, eds. Sunscreens: Development, Evaluation, and Regulatory Aspects. 2nd ed. New York, NY: Marcel Dekker Inc; 1997:601-610.
11. Carabott FM, Hawk JLM. A modified dosage schedule for increased efficiency in PUVA treatment of psoriasis. Clin Exp Dermatol. 1989;14:337-340.
12. Fredriksson T, Pettersson U. Severe psoriasis: oral therapy with a new retinoid. Dermatologica. 1978;157:238-244.
13. Melski JW, Tanenbaum L, Parrish JA, Fitzpatrick TB, Bleich HL. Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial. J Invest Dermatol. 1977;68:328-335.
14. Morison WL. Phototherapy and Photochemotherapy of Skin Disease. 2nd ed. New York, NY: Raven Press Ltd; 1991:100.
15. Stern RS, Nichols KT, Väkevä LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). N Engl J Med. 1997;336:1041-1045.